Home LiteratureArticle Details
PMID: 2891768 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Regulation of T cell clone function via CD4 and CD8 molecules. Anti-CD4 can mediate two distinct inhibitory activities.

Journal of immunology (Baltimore, Md. : 1950) ·Vol. 140 ·No. 2 ·1988-01-15 ·Pages 376-83

Blue ML, Hafler DA, Daley JF, Levine H, Craig KA, Breitmeyer JB, Schlossman SF

Abstract

The functional effects resulting from CD4 and CD8 perturbation were analyzed by using a CD4+CD8+ clone and anti-CD4 and anti-CD8 monoclonal antibodies. Perturbation of CD8, but not CD4, by soluble antibody resulted in the inhibition of CD3-T cell receptor (CD3-Ti) triggering as determined by flow cytometric measurements of intracellular free Ca2+ concentrations. In addition, the CD3-T cell receptor-mediated cytotoxic function of the CD4+CD8+ clone was inhibited by anti-CD8, but not by anti-CD4. These results suggest that CD8, but not CD4, was functionally associated with CD3-Ti on the CD4+CD8+ clone. Although CD4 perturbation did not affect CD3-Ti-mediated activities, it resulted in the inhibition of the interleukin 2-dependent proliferation of this clone. Perturbation of CD8 did not affect the interleukin 2 dependent proliferation of the CD4+CD8+ clone. On the other hand, CD4 molecules of another CD4+CD8- clone unlike those of the CD4+CD8+ clone, were clearly linked to T cell receptor function. These results indicate that CD4 perturbation can result in two distinct regulatory activities; one involves the regulation of CD3-T cell receptor function, whereas the other is not directly associated with CD3-T cell antigen receptor function. The data are also consistent with the notion that CD4 and CD8 do not merely function as recognition and adhesion elements for accessory cell major histocompatibility complex molecules, but have a direct role in the regulation of T cell activation.

MeSH Terms
Antibodies, Monoclonal/physiology Antigens, Differentiation, T-Lymphocyte/immunology Clone Cells/classification,immunology,metabolism Cytotoxicity, Immunologic Humans Interleukin-2/pharmacology Lymphocyte Activation Male Middle Aged Phenotype Receptors, Antigen, T-Cell/metabolism T-Lymphocytes/classification,immunology,metabolism
Chemicals
Antibodies, Monoclonal Antigens, Differentiation, T-Lymphocyte Interleukin-2 Receptors, Antigen, T-Cell
Authors & Affiliations
7 authors, click to expand affiliations / ORCID
Blue M L
Division of Tumor Immunology, Dana-Farber Cancer Institute, Boston, MA 02115.
Hafler D A
Daley J F
Levine H
Craig K A
Breitmeyer J B
Schlossman S F
Article Info
Journal
Journal of immunology (Baltimore, Md. : 1950)
Abbr.
J Immunol
ISSN
0022-1767
Published
1988-01-15
Pages
376-83
Language
English
Region
United States
NLM ID
2985117R
Subset
IM
Grants
NIAID NIH HHS · AI 12069 · United States
NIAID NIH HHS · AI 23392 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com